에볼루션 바카라사이트 lays the foundation for overseas market expansion through entry into the Japanese market
[by Ji, Yong Jun] LaMeditech, a company specializing in laser-based healthcare solutions, announced on May 27 the signing of a supply agreement with its Japanese partner, GUNZE MEDICAL, for the provision of ‘CAREVEAM,’ an excimer light irradiation device developed for the treatment of dermatological conditions.
The excimer light irradiator CAREVEAM is a 에볼루션 바카라사이트 device designed for the treatment of dermatological conditions, utilizing a 308nm UVB wavelength. It is primarily indicated for autoimmune disorders such as vitiligo and psoriasis, as well as various inflammatory skin diseases. According to the company, CAREVEAM distinguishes itself in the global market through its significantly lighter weight, compact size, and user-friendly design. These attributes, combined with performance and cost competitiveness that surpass those of comparable devices, have garnered attention from prospective buyers.
In particular, following the acquisition of a manufacturing and sales certificate from the Pharmaceuticals and 에볼루션 바카라사이트 Devices Agency (PMDA), under the jurisdiction of the Japanese Ministry of Health, Labour, and Welfare, in early May, the company anticipates a full-scale entry into the Japanese market. Sales are expected to begin in earnest through GUNZE 에볼루션 바카라사이트, which possesses a distribution network of over 1,000 hospitals across Japan, upon the sealing of the supply agreement.
“In addition to 에볼루션 바카라사이트, regulatory certifications have either been completed or are currently underway in several other international markets, including Iran, Taiwan, Turkey, and Sri Lanka. Hence, we anticipate a further acceleration in the expansion of our overseas sales activities in the near future,” a company official said.